A real world study for post-market re-evaluation of traditional Chinese medicine injection

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024340

Enrollment

Unknown

Registered

2019-07-06

Start date

2019-06-30

Completion date

Unknown

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease

Interventions

Case series:Using traditional Chinese medicine injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. The clinic of the First Affiliated Hospital of Bengbu Medical College is diagnosed as a patient with cardiovascular and cerebrovascular diseases; 2. The Chinese medicine injection is used to treat these diseases, regardless of gender, age or race.

Exclusion criteria

Exclusion criteria: In patients with other diseases, patients who have not been treated with traditional Chinese medicine injections have a total survival of no more than 3 months.

Design outcomes

Primary

Measure	Time frame
Adverse reactions;	—

Countries

China

Contacts

Public ContactShi Qingping

The First Affiliated Hospital of Bengbu Medical College

sir_shi@126.com+86 13855288331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026